Angiex selected ZingPR to generate excitement and build momentum for the Phase 1 clinical trial of AGX101, a novel antibody-drug conjugate (ADC) designed to revolutionize cancer treatment by targeting tumor blood vessels. The campaign played a crucial role in communicating the potential of AGX101 to transform cancer treatment and attracting support for Angiex's mission.

WideTrial, a startup focused on expanded access programs (EAPs), partnered with ZingPR to announce its role in a major NIH-funded EAP for ALS. The challenge was to generate excitement while establishing credibility and navigating the constraints faced by many startups. How ZingPR helped WideTrial achieve significant media coverage in prominent publications.

Recently, I had the chance to work on a fascinating project: promoting a debate on aging. Not your typical PR gig, right? But that's what I love about this field—the chance to work with innovative companies tackling big challenges. My goal was simple: make this debate unmissable. And more importantly, make it matter. Because the science behind it really matters.

ZingPR helped Transform Materials, a Florida-based deeptech startup, announce a groundbreaking collaboration with Johnson Matthey that's set to revolutionize the PVC industry. Our strategic media outreach focused on highlighting the partnership's environmental benefits, scalability, and industry-leading expertise.

In the world of science PR, it's not enough to have groundbreaking research – you need a story that grips. A narrative that not only informs but also intrigues. So how do you break through the clutter and make your science news sing?